Columbia Care is First and Only U.S. Multistate Cannabis Operator to be Included in a Major Global Benchmark Index
NEW YORK, November 30, 2021--(BUSINESS WIRE)--Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) ("Columbia Care" or the "Company), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced that MSCI Inc. ("MSCI"), a leading provider of critical decision support tools and services for the global investment community, has added Columbia Care to the MSCI Canada Small Cap Index, as of market close on November 30. Columbia Care is the first and only U.S.-based cannabis company to be added to a major benchmarking index.
"This is a landmark achievement for Columbia Care and the cannabis industry that opens the door for the global institutional investment community to gain exposure in a meaningful and established way. Our inclusion in MSCI index benchmarks is a testament to the quality, good governance and growth trajectory of Columbia Care, as well as our commitment to drive shareholder value," said Nicholas Vita, Chief Executive Officer of Columbia Care. "We appreciate the credibility and visibility that accompany inclusion in an MSCI index. We are grateful to the NEO Exchange for their support since we began trading as ‘CCHW’ in April 2019, and are proud to be partnered with this senior exchange that enabled such a groundbreaking achievement."
The MSCI Canada Small Cap Index is designed to measure the performance of the small cap segment of the Canada market. With 196 constituents, the index covers approximately 14% of the free float-adjusted market capitalization in Canada. Columbia Care was deemed eligible and selected for inclusion within the MSCI Global Equity Indexes based upon a rigorous methodology that considers a number of factors, including liquidity, governance, momentum and market capitalization. MSCI estimates more than $16 trillion in assets under management are benchmarked to MSCI indexes.
In May 2021, NEO announced that MSCI recognized the NEO Exchange as an eligible market for inclusion in MSCI Indexes under the MSCI Global Investable Market Indexes Methodology.
For more information about Columbia Care visit www.col-care.com.
About Columbia Care Inc.
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.col-care.com.
Caution Concerning Forward-Looking Statements
This press release contains certain statements that constitute forward-looking information within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. The Company has made assumptions with regard to its ability to execute on brand and product initiatives, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. Securityholders should review the risk factors discussed under "Risk Factors" in Columbia Care’s Annual Information Form dated March 31, 2021, filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com and described from time to time in documents filed by the Company with Canadian securities regulatory authorities.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211130006123/en/
Lee Ann Evans